Sutro Biopharma Investors

17 investors on Angel Roster list Sutro Biopharma in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Sutro Biopharma can appear together.

Investors listed
17
With verified email
35%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 Sutro Biopharma investors

The most complete profiles first. Showing 17 of 17.

  • Eugene HillVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Verified email available

  • Jack KenneyVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Paul LaVioletteVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Verified email available

  • Tom FlynnVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Daniel OmsteadVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more

    Verified email available

  • Elizabeth Blake SchwertVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Mike RossVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Gregory Madden

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Contact details available

  • Houman Ashrafian

    Venture Capital, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Michael Balmuth

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Pete Hudson, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsGeneticsWomen Founded

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Bob More

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Brent Faduski

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carl Culicchia

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Ed Torres

    Corporate Venture Capital · United States

    Health CareAlternative MedicineWomen FoundedInformation Technology (IT)

    Portfolio: Avid Radiopharmaceuticals, GlobeImmune, Sutro Biopharma, Cerulean Pharma and 30 more

    Contact details available

  • Jason Akus

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more

    Contact details available

  • Mike Dybbs

    Venture Capital, Investor · United States

    Series BBiotechnologyElectronic Health Records (EHR)

    Portfolio: Versartis, Principia Biopharma, Nkarta Therapeutics, Advanced Cell Diagnostics and 3 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Sutro Biopharma investors are on Angel Roster?

Angel Roster lists 17 Sutro Biopharma investors. 6 of them (35%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (5) and Corporate Venture Capital Firms (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Sutro Biopharma investors invest in?

Among those that list a stage, the most common are Seed (8) and Series B (1).

Where are Sutro Biopharma investors based?

Most are based in the United States (16) and the United Kingdom (1).

Which companies have Sutro Biopharma investors backed?

The most-backed portfolio companies among them are CardioKinetix (13), Pionyr Immunotherapeutics (11), Cibiem, Inc. (11), Schweiger Dermatology (11) and Ribometrix (11).

How do I contact Sutro Biopharma investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.